Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical benzyl benzoate vs permethrin for scabies treatment
2022-000660-22Phase 3Completed
- Sponsor
- Landeskrankenhaus Salzburg
- Start
- Mar 2022
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of benzyl benzoate and permethrin in scabies (2 arms), sponsored by Landeskrankenhaus Salzburg. Started Mar 2022; status: completed.
02
Drugs
benzyl benzoatepermethrin
03
Conditions
scabies
Beyond the preview
Go deeper on 2022-000660-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000660-22.